Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06027554
PHASE2

The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults

Sponsor: UConn Health

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to test the effects of MitoQ supplementation in older adults and frail older adults with physical dysfunction and/or cognitive dysfunction. The main question\[s\] it aims to answer are: * To compare vascular function, oxidative stress levels, and physical and cognitive function among older adults and frail older adults with physical and cognitive dysfunction * To determine whether MitoQ supplementation has the potential to improve vascular function in central and cerebral vessels * To determine whether MitoQ supplementation can enhance physical and cognitive capabilities.

Key Details

Gender

All

Age Range

65 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-10-07

Completion Date

2028-02-01

Last Updated

2026-01-09

Healthy Volunteers

Yes

Interventions

DRUG

Mitoquinone Mesylate

MitoQ given 20 mg per day for 12 weeks.

DIETARY_SUPPLEMENT

Placebo capsule

Placebo capsule taken every day for 12 weeks.

Locations (1)

UConn Health

Farmington, Connecticut, United States